Target Price | $14.33 |
Price | $12.27 |
Potential |
16.82%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Summit Therapeutics PLC Sponsored ADR 2025 .
The average Summit Therapeutics PLC Sponsored ADR target price is $14.33.
This is
16.82%
register free of charge
$16.00
30.40%
register free of charge
$13.00
5.95%
register free of charge
|
|
A rating was issued by 3 analysts: 3 Analysts recommend Summit Therapeutics PLC Sponsored ADR to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Summit Therapeutics PLC Sponsored ADR stock has an average upside potential 2025 of
16.82%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.99 | -0.34 |
141.46% | 65.66% | |
P/E | negative |
Summit Therapeutics PLC Sponsored ADR...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.